Toll-Like Receptor Ligands Induce Expression of the Costimulatory Molecule CD155 on Antigen-Presenting Cells

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Kamran, Neha ^a   Takai, Yoshimi ^b   Miyoshi, Jun ^c   Biswas, Subhra K ^d   Wong, Justin S B ^a   Gasser, Stephan ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^d AGENCY FOR SCIENCE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; DECAY ACCELERATING FACTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2C; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 4; MYELOID DIFFERENTIATION FACTOR 88; OVALBUMIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNIZATION; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SPLEEN CELL; UPREGULATION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DNA DAMAGE; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; IMMUNITY, HUMORAL; LIGANDS; MICE; MYELOID DIFFERENTIATION FACTOR 88; RECEPTORS, VIRUS; SPLEEN; TH2 CELLS; TOLL-LIKE RECEPTOR 3; VIRAL VACCINES;

MUS;

EID: 84872540485     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054406     Document Type: Article

References (63)

1. Kawai T, Akira S, (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11: 373-384.
2. Iwasaki A, Medzhitov R, (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5: 987-995.
3. Akira S, Takeda K, Kaisho T, (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nature immunology 2: 675-680.
4. Liew FY, (2002) T(H)1 and T(H)2 cells: a historical perspective. Nature reviews Immunology 2: 55-60.
5. Thompson CB, (1995) Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 81: 979-982.
6. Barton GM, Medzhitov R, (2002) Control of adaptive immune responses by Toll-like receptors. Current opinion in immunology 14: 380-383.
7. Redecke V, Hacker H, Datta SK, Fermin A, Pitha PM, et al. (2004) Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. Journal of immunology 172: 2739-2743.
8. Mendelsohn CL, Wimmer E, Racaniello VR, (1989) Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 56: 855-865.
9. Takai Y, Irie K, Shimizu K, Sakisaka T, Ikeda W, (2003) Nectins and nectin-like molecules: roles in cell adhesion, migration, and polarization. Cancer Sci 94: 655-667.
10. Chadeneau C, LeMoullac B, Denis MG, (1994) A novel member of the immunoglobulin gene superfamily expressed in rat carcinoma cell lines. J Biol Chem 269: 15601-15605.
11. Xu Z, Jin B, (2010) A novel interface consisting of homologous immunoglobulin superfamily members with multiple functions. Cellular & molecular immunology 7: 11-19.
12. Pende D, Castriconi R, Romagnani P, Spaggiari GM, Marcenaro S, et al. (2006) Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction. Blood 107: 2030-2036.
13. Soriani A, Zingoni A, Cerboni C, Iannitto ML, Ricciardi MR, et al. (2009) ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood 113: 3503-3511.
14. Hirota T, Irie K, Okamoto R, Ikeda W, Takai Y, (2005) Transcriptional activation of the mouse Necl-5/Tage4/PVR/CD155 gene by fibroblast growth factor or oncogenic Ras through the Raf-MEK-ERK-AP-1 pathway. Oncogene 24: 2229-2235.
15. Seth S, Maier MK, Qiu Q, Ravens I, Kremmer E, et al. (2007) The murine pan T cell marker CD96 is an adhesion receptor for CD155 and nectin-1. Biochem Biophys Res Commun.
16. Yu X, Harden K, Gonzalez LC, Francesco M, Chiang E, et al. (2009) The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat Immunol 10: 48-57.
17. Bottino C, Castriconi R, Pende D, Rivera P, Nanni M, et al. (2003) Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med 198: 557-567.
18. Shibuya A, Campbell D, Hannum C, Yssel H, Franz-Bacon K, et al. (1996) DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 4: 573-581.
19. Dardalhon V, Schubart AS, Reddy J, Meyers JH, Monney L, et al. (2005) CD226 is specifically expressed on the surface of Th1 cells and regulates their expansion and effector functions. Journal of immunology 175: 1558-1565.
20. Shibuya K, Shirakawa J, Kameyama T, Honda S, Tahara-Hanaoka S, et al. (2003) CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation. J Exp Med 198: 1829-1839.
21. Wang PL, O'Farrell S, Clayberger C, Krensky AM, (1992) Identification and molecular cloning of tactile. A novel human T cell activation antigen that is a member of the Ig gene superfamily. Journal of immunology 148: 2600-2608.
22. Pende D, Bottino C, Castriconi R, Cantoni C, Marcenaro S, et al. (2005) PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis. Mol Immunol 42: 463-469.
23. Fuchs A, Cella M, Giurisato E, Shaw AS, Colonna M, (2004) Cutting edge: CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155). J Immunol 172: 3994-3998.
24. Gilfillan S, Chan CJ, Cella M, Haynes NM, Rapaport AS, et al. (2008) DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors. J Exp Med 205: 2965-2973.
25. Levin SD, Taft DW, Brandt CS, Bucher C, Howard ED, et al. (2011) Vstm3 is a member of the CD28 family and an important modulator of T-cell function. Eur J Immunol 41: 902-915.
26. Schmitz F, Mages J, Heit A, Lang R, Wagner H, (2004) Transcriptional activation induced in macrophages by Toll-like receptor (TLR) ligands: from expression profiling to a model of TLR signaling. European journal of immunology 34: 2863-2873.
27. Mizel SB, Honko AN, Moors MA, Smith PS, West AP, (2003) Induction of macrophage nitric oxide production by Gram-negative flagellin involves signaling via heteromeric Toll-like receptor 5/Toll-like receptor 4 complexes. Journal of immunology 170: 6217-6223.
28. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, et al. (2003) Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301: 640-643.
29. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, et al. (2001) The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410: 1099-1103.
30. Akira S, Takeda K, (2004) Toll-like receptor signalling. Nature reviews Immunology 4: 499-511.
31. Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U, (1995) Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267: 1485-1488.
32. Aggarwal BB, (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nature reviews Immunology 3: 745-756.
33. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N, (2001) IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 19: 623-655.
34. Kawai T, Sato S, Ishii KJ, Coban C, Hemmi H, et al. (2004) Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 5: 1061-1068.
35. Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, et al. (2003) Triggering the interferon antiviral response through an IKK-related pathway. Science 300: 1148-1151.
36. Hacker H, Karin M, (2006) Regulation and function of IKK and IKK-related kinases. Sci STKE 2006: re13.
37. Bonnard M, Mirtsos C, Suzuki S, Graham K, Huang J, et al. (2000) Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. The EMBO journal 19: 4976-4985.
38. Klinman DM, (2006) Adjuvant activity of CpG oligodeoxynucleotides. Int Rev Immunol 25: 135-154.
39. Pasare C, Medzhitov R, (2005) Control of B-cell responses by Toll-like receptors. Nature 438: 364-368.
40. Schnare M, Barton GM, Holt AC, Takeda K, Akira S, et al. (2001) Toll-like receptors control activation of adaptive immune responses. Nature immunology 2: 947-950.
41. Barr TA, Brown S, Mastroeni P, Gray D, (2009) B cell intrinsic MyD88 signals drive IFN-gamma production from T cells and control switching to IgG2c. Journal of immunology 183: 1005-1012.
42. Gilfillan S, Chan CJ, Cella M, Haynes NM, Rapaport AS, et al. (2008) DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors. The Journal of experimental medicine 205: 2965-2973.
43. Jouvin-Marche E, Morgado MG, Leguern C, Voegtle D, Bonhomme F, et al. (1989) The mouse Igh-1a and Igh-1b H chain constant regions are derived from two distinct isotypic genes. Immunogenetics 29: 92-97.
44. Martin RM, Brady JL, Lew AM, (1998) The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. Journal of immunological methods 212: 187-192.
45. Murphy KM, Reiner SL, (2002) The lineage decisions of helper T cells. Nat Rev Immunol 2: 933-944.
46. Andersen J, VanScoy S, Cheng TF, Gomez D, Reich NC, (2008) IRF-3-dependent and augmented target genes during viral infection. Genes and immunity 9: 168-175.
47. Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, et al. (2005) Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434: 243-249.
48. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, et al. (1995) Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology 9: 899-909.
49. Schnare M, Barton GM, Holt AC, Takeda K, Akira S, et al. (2001) Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2: 947-950.
50. Krieg AM, (2000) The role of CpG motifs in innate immunity. Curr Opin Immunol 12: 35-43.
51. Klinman DM, (2004) Immunotherapeutic uses of CpG oligodeoxynucleotides. Nature reviews Immunology 4: 249-258.
52. Lin L, Gerth AJ, Peng SL, (2004) CpG DNA redirects class-switching towards "Th1-like" Ig isotype production via TLR9 and MyD88. Eur J Immunol 34: 1483-1487.
53. Xu H, Heeger PS, Fairchild RL, (1997) Distinct roles for B7-1 and B7-2 determinants during priming of effector CD8+ Tc1 and regulatory CD4+ Th2 cells for contact hypersensitivity. J Immunol 159: 4217-4226.
54. De Becker G, Moulin V, Tielemans F, De Mattia F, Urbain J, et al. (1998) Regulation of T helper cell differentiation in vivo by soluble and membrane proteins provided by antigen-presenting cells. Eur J Immunol 28: 3161-3171.
55. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, et al. (2005) IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777.
56. Abe A, Fukui H, Fujii S, Kono T, Mukawa K, et al. (2009) Role of Necl-5 in the pathophysiology of colorectal lesions induced by dimethylhydrazine and/or dextran sodium sulphate. The Journal of pathology 217: 42-53.
57. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, et al. (1998) Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9: 143-150.
58. Sasaki T, Gan EC, Wakeham A, Kornbluth S, Mak TW, et al. (2007) HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53. Genes Dev 21: 848-861.
59. Hemmi H, Takeuchi O, Sato S, Yamamoto M, Kaisho T, et al. (2004) The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J Exp Med 199: 1641-1650.
60. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, et al. (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. The Journal of experimental medicine 176: 1693-1702.
61. Zamboni DS, Rabinovitch M, (2003) Nitric oxide partially controls Coxiella burnetii phase II infection in mouse primary macrophages. Infection and immunity 71: 1225-1233.
62. Boehm JS, Zhao JJ, Yao J, Kim SY, Firestein R, et al. (2007) Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 129: 1065-1079.
63. Gasser S, Orsulic S, Brown EJ, Raulet DH, (2005) The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436: 1186-1190.